Delineation of RAID1, the RACK1 interaction domain located within the unique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5
Tóm tắt
The cyclic AMP specific phosphodiesterase, PDE4D5 interacts with the β-propeller protein RACK1 to form a signaling scaffold complex in cells. Two-hybrid analysis of truncation and mutant constructs of the unique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5 were used to define a domain conferring interaction with the signaling scaffold protein, RACK1. Truncation and mutagenesis approaches showed that the RACK1-interacting domain on PDE4D5 comprised a cluster of residues provided by Asn-22/Pro-23/Trp-24/Asn-26 together with a series of hydrophobic amino acids, namely Leu-29, Val-30, Leu-33, Leu-37 and Leu-38 in a 'Leu-Xaa-Xaa-Xaa-Leu' repeat. This was done by 2-hybrid analyses and then confirmed in biochemical pull down analyses using GST-RACK1 and mutant PDE4D5 forms expressed in COS cells. Mutation of Arg-34, to alanine, in PDE4D5 attenuated its interaction with RACK1 both in 2-hybrid screens and in pull down analyses. A 38-mer peptide, whose sequence reflected residues 12 through 49 of PDE4D5, bound to RACK1 with similar affinity to native PDE4D5 itself (Ka circa 6 nM). The RA CK1 I nteraction D omain on PDE4D5, that we here call RAID1, is proposed to form an amphipathic helical structure that we suggest may interact with the C-terminal β-propeller blades of RACK1 in a manner akin to the interaction of the helical G-γ signal transducing protein with the β-propeller protein, G-β.
Tài liệu tham khảo
Houslay MD, Milligan G: Tailoring cAMP signalling responses through isoform multiplicity. Trends in Biochemical Sciences. 1997, 22: 217-224. 10.1016/S0968-0004(97)01050-5.
Kammer GM: The adenylate cyclase-cAMP-protein kinase pathway and regulation of the immune response. Immunology Today. 1988, 9: 222-229. 10.1016/0167-5699(88)91220-0.
Lerner A, Kim DH, Lee R: The cAMP signaling pathway as a therapeutic target in lymphoid malignancies. Leuk Lymphoma. 2000, 37: 39-51.
Manganiello VC, Smith CJ, Degerman E, Vasta V, Tornqvist H, Belfrage P: Molecular mechanisms involved in the antilipolytic action of insulin: Phosphorylation and activation of a particulate adipocyte cAMP phosphodiesterase. Advances in Experimental Medicine and Biology. 1991, 293: 239-248.
Murphy BJ, Scott JD: Functional anchoring of the cAMP-dependent protein kinase. Trends in Cardiovascular Medicine. 1998, 8: 89-95. 10.1016/S1050-1738(97)00131-X.
Beavo JA: Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiological Reviews. 1995, 75: 725-748.
Bolger G: Molecular Biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes. Cellular Signalling. 1994, 6: 851-859. 10.1016/0898-6568(94)90018-3.
Conti M, Jin SLC: The molecular Biology of cyclic nucleotide phosphodiesterases. Progress in Nucleic Acid Research. 1999, 63: 1-38.
Dousa TP: Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int. 1999, 55: 29-62. 10.1046/j.1523-1755.1999.00233.x.
Houslay MD, Sullivan M, Bolger GB: The multi-enzyme PDE4 cyclic AMP specific phosphodiesterase family: intracellular targeting, regulation and selective inhibition by compounds exerting anti-inflammatory and anti-depressant actions. Advances in Pharmacology. 1998, 44: 225-342.
Manganiello VC, Murata T, Taira M, Belfrage P, Degerman E: Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Archives of Biochemistry and Biophysics. 1995, 322: 1-13. 10.1006/abbi.1995.1429.
Manganiello VC, Taira M, Degerman E, Belfrage P: Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE 3 gene family). Cellular Signalling. 1995, 7: 445-455. 10.1016/0898-6568(95)00017-J.
Torphy TJ: Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am J Respir Crit Care Med. 1998, 157: 351-70.
Souness JE, Rao S: Proposal for pharmacologically distinct conformers of PDE4. Cellular Signalling. 1997, 9: 227-236. 10.1016/S0898-6568(96)00173-8.
Giembycz MA: Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?. Drugs. 2000, 59: 193-212.
Beard MB, Olsen AE, Jones RE, Erdogan S, Houslay MD, Bolger GB: UCR1 and UCR2 Domains Unique to the cAMP-specific Phosphodiesterase (PDE4) Family Form a Discrete Module via Electrostatic Interactions. Journal of Biological Chemistry. 2000, 275: 10349-58. 10.1074/jbc.275.14.10349.
Hoffmann R, Wilkinson IR, McCallum JF, Engels P, Houslay MD: cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: Generation of a molecular model. Biochemical Journal. 1998, 333: 139-149.
Sette C, Conti M: Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. Journal of Biological Chemistry. 1996, 271: 16526-16534. 10.1074/jbc.271.28.16526.
MacKenzie SJ, Baillie GS, McPhee I, Bolger GB, Houslay MD: ERK2 MAP kinase binding, phosphorylation and regulation of PDE4D cAMP specific phosphodiesterases: the involvement of C-terminal docking sites and N-terminal UCR regions. J. Biol. Chem. 2000, 275: 16609-16617. 10.1074/jbc.275.22.16609.
Houslay MD: The N-terminal alternately spliced regions of PDE4A cAMP-specific phosphodiesterases determine intracellular targeting and regulation of catalytic activity. Biochemical Society Transactions. 1996, 24: 980-986.
Pooley L, Shakur Y, Rena G, Houslay MD: Intracellular localisation of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in transfected human thyroid carcinoma FTC cell lines. Biochemical Journal. 1997, 271: 177-185.
Shakur Y, Wilson M, Pooley L, Lobban M, Griffiths SL, Campbell AM, Beattie J, Daly C, Houslay MD: Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum. Biochemical Journal. 1995, 306: 801-809.
Huston E, Pooley L, Julien J, Scotland G, McPhee I, Sullivan M, Bolger G, Houslay MD: The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species which exhibit distinct kinetics of inhibition by the anti-depressant rolipram. J. Biol. Chem. 1996, 271: 31334-31344. 10.1074/jbc.271.49.31334.
Huston E, Beard M, McCallum F, Pyne NJ, Vandenabeele P, Scotland G, Houslay MD: The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3: consequences for altered intracellular distribution. J Biol Chem. 2000, 275: 28063-74.
Bolger GB, Erdogan S, Jones RE, Loughney K, Scotland G, Hoffmann R, Wilkinson I, Farrell C, Houslay MD: Characterisation of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. Biochemical Journal. 1997, 328: 539-548.
Yarwood SJ, Steele MR, Scotland G, Houslay MD, Bolger GB: The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform. J Biol Chem. 1999, 274: 14909-17. 10.1074/jbc.274.21.14909.
Mochly-Rosen D, Khaner H, Lopez J: Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci U S A. 1991, 88: 3997-4000.
Ron D, Chen CH, Caldwell J, Jamieson L, Orr E, Mochly-Rosen D: Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins [published erratum appears in Proc Natl Acad Sci U S A 1995 Feb 28;92(5):2016]. Proc Natl Acad Sci U S A. 1994, 91: 839-43.
Mochly-Rosen D, Smith BL, Chen CH, Disatnik MH, Ron D: Interaction of protein kinase C with RACK1, a receptor for activated C-kinase: a role in beta protein kinase C mediated signal transduction. Biochem Soc Trans. 1995, 23: 596-600.
Rodriguez MM, Ron D, Touhara K, Chen CH, Mochly-Rosen D: RACK1, a protein kinase C anchoring protein, coordinates the binding of activated protein kinase C and select pleckstrin homology domains in vitro. Biochemistry. 1999, 38: 13787-94. 10.1021/bi991055k.
Liliental J, Chang DD: RACK1, a receptor for activated protein kinase C, interacts with integrin beta subunit. J Biol Chem. 1998, 273: 2379-83. 10.1074/jbc.273.4.2379.
Geijsen N, Spaargaren M, Raaijmakers JA, Lammers JW, Koenderman L, Coffer PJ: Association of RACK1 and PKCbeta with the common beta-chain of the IL-5/IL-3/GM-CSF receptor. Oncogene. 1999, 18: 5126-30. 10.1038/sj.onc.1202896.
Smith PR, de Jesus O, Turner D, Hollyoake M, Karstegl CE, Griffin BE, Karran L, Wang Y, Hayward SD, Farrell PJ: Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J Virol. 2000, 74: 3082-92. 10.1128/JVI.74.7.3082-3092.2000.
Chang BY, Conroy KB, Machleder EM, Cartwright CA: RACK1, a receptor for activated C kinase and a homolog of the beta subunit of G proteins, inhibits activity of Src tyrosine kinases and growth of NIH 3T3 cells. Molecular & Cellular Biology. 1998, 18: 3245-3256.
Sondek J, Bohm A, Lambright DG, Hamm HE, Sigler PB: Crystal structure of a G-protein beta gamma dimer at 2.1A resolution. Nature. 1996, 379: 369-74. 10.1038/379369a0.
Wall MA, Coleman DE, Lee E, Iniguez-Lluhi JA, Posner BA, Gilman AG, Sprang SR: The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. Cell. 1995, 83: 1047-58. 10.1016/0092-8674(95)90220-1.
Csukai M, Chen CH, De Matteis MA, Mochly-Rosen D: The coatomer protein beta'-COP, a selective binding protein (RACK) for protein kinase Cepsilon. J Biol Chem. 1997, 272: 29200-6. 10.1074/jbc.272.46.29200.
Bolger G, Michaeli T, Martins T, St John T, Steiner B, Rodgers L, Riggs M, Wigler M, Ferguson K: A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Molecular and Cellular Biology. 1993, 13: 6558-6571.
Yarwood SJ, Steele MR, Scotland G, Houslay MD, Bolger GB: The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform (eratum). J Biol Chem. 2001, 276: 6879-
Monera OD, Zhou NE, Lavigne P, Kay CM, Hodges RS: Formation of parallel and antiparallel coiled-coils controlled by the relative positions of alanine residues in the hydrophobic core. J Biol Chem. 1996, 271: 3995-4001. 10.1074/jbc.271.8.3995.
Monera OD, Sonnichsen FD, Hicks L, Kay CM, Hodges RS: The relative positions of alanine residues in the hydrophobic core control the formation of two-stranded or four-stranded alpha-helical coiled-coils. Protein Eng. 1996, 9: 353-63.
Zhou NE, Kay CM, Hodges RS: The net energetic contribution of interhelical electrostatic attractions to coiled-coil stability. Protein Eng. 1994, 7: 1365-72.
Pellegrino S, Zhang S, Garritsen A, Simonds WF: The coiled-coil region of the G protein beta subunit. Mutational analysis of Ggamma and effector interactions. J Biol Chem. 1997, 272: 25360-6. 10.1074/jbc.272.40.25360.
Rost B: PHD: predicting one-dimensional protein structure by profile-based neural networks. Methods Enzymol. 1996, 266: 525-39.
Lambright DG, Sondek J, Bohm A, Skiba NP, Hamm HE, Sigler PB: The 2.0 A crystal structure of a heterotrimeric G protein. Nature. 1996, 379: 311-9. 10.1038/379311a0.
Steele MR, McCahill A, Thompson DS, MacKenzie C, Isaacs NW, Houslay MD, Bolger GB: Identification of a surface on the β-propeller protein RACK1 that interacts with the cAMP specific phosphodiesterase PDE4D5. Cell. Signal. 2001, 13: 507-513. 10.1016/S0898-6568(01)00167-X.
Sondek J, Siderovski DP: Ggamma-like (GGL) domains: new frontiers in G-protein signaling and beta-propeller scaffolding. Biochem Pharmacol. 2001, 61: 1329-37. 10.1016/S0006-2952(01)00633-5.
Colledge M, Scott JD: AKAPs: From structure to function. Trends in Cell Biology. 1999, 9: 216-221. 10.1016/S0962-8924(99)01558-5.
Rubin CS: A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP. Biochimica et Biophysica Acta. 1994, 1224: 467-479.
Kreis TE, Lodish HF: Oligomerization is essential for transport of vesicular stomatitis viral glycoprotein to the cell surface. Cell. 1986, 46: 929-937. 10.1016/0092-8674(86)90075-9.
Beard MB, O'Connell JC, Bolger GB, Houslay MD: The unique N-terminal domain of the cAMP phosphodiesterase PDE4D4 allows for interaction with specific SH3 domains. FEBS Lett. 1999, 460: 173-7. 10.1016/S0014-5793(99)01335-6.
Bolger GB: Molecular genetic approaches. I. Two-hybrid systems. Methods Mol Biol. 1998, 88: 101-31. 10.1385/0-89603-487-9:101.
Bradford M: Protein determination in biological samples. Analytical Biochemistry. 1976, 72: 248-254. 10.1006/abio.1976.9999.
Sali A, Blundell TL: Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993, 234: 779-815. 10.1006/jmbi.1993.1626.
Guex N, Peitsch MC: SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997, 18: 2714-23. 10.1002/elps.1150181505.